CHD Chemicals Q1 Results: Net loss widens 20% YoY to ₹12.3 lakh
CHD Chemicals reported a wider Q1 FY27 net loss of ₹12.27 lakh, down from ₹15.43 lakh in Q1 FY26. Revenue from operations rose 28% YoY to ₹162.42 lakh, but total expenses increased 17% to ₹175.15 lakh. Other income fell to ₹0.46 lakh from ₹7.90 lakh. EPS remained negative at about ₹-0.12. Results were approved Aug 14, 2026.
How this was made
The 30-second read
Why it matters
The key trading takeaway is that top-line growth did not translate into profitability, with a major deterioration in other income and higher operating expenses keeping EPS negative.
Market read
Traders may reprice near-term earnings risk due to widening loss drivers: other income collapse and rising total expenses, despite revenue growth.
What to watch
The article does not break out segment margins, inventory/working-capital changes, or guidance, so the sustainability of the cost increase and other-income decline is unclear.
Background
CHD Chemicals Limited released unaudited Q1FY27 financial results under Ind AS, reviewed by GAMS & Associates LLP, and also disclosed a non-executive director resignation.
Ticker impact
CHD Chemicals reported Q1FY27 net loss of ₹12.27 lakh and revenue growth, with profitability worsening due to higher operating costs and lower other income.
Bias to negative/volatile trading until cost structure and non-operating income stabilize.
The article provides concrete quarterly P&L deltas: revenue from operations +28% YoY, total expenses +17% YoY, other income collapsing from ₹7.90 lakh to ₹0.46 lakh, and net loss improving only modestly (-20% YoY) while remaining negative.
Market effects
Signals margin pressure risk for small-cap chemical producers where non-operating income may have previously cushioned losses.
India-listed small-cap sentiment could soften if investors extrapolate cost inflation and weaker non-operating income.
Limited, as the disclosure is company-specific and not tied to global macro or cross-border events.
Counterpoint
Revenue growth (+28% YoY) and slightly improved net loss (-20% YoY) could indicate operating leverage is improving, even if margins are still weak.
Key entities
- companyCHD Chemicals Limited
Subject of the article, reporting Q1FY27 net loss and other income decline alongside higher expenses.
- personMrs. Santosh Rani
Non-executive, non-independent director whose resignation was accepted effective June 22, 2026.
- auditorGAMS & Associates LLP
Reviewed the unaudited financial results under SRE 2410.
- venueBSE Ltd
Exchange where the Regulation 30 disclosure was filed.
